What is a Patient Information Leaflet and why is it useful?

The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.

Below is a text only representation of the Patient Information Leaflet. The original leaflet can be viewed using the link above.

The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PL 25258/0095 .


Zolmitriptan 2.5 mg and 5 mg Orodispersible Tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER

Zolmitriptan 2.5 mg Orodispersible Tablets

Zolmitriptan 5 mg Orodispersible Tablets

zolmitriptan

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

What is in this leaflet:

1. What Zolmitriptan Orodispersible Tablets is and what it is used for
2. What you need to know before you take Zolmitriptan Orodispersible Tablets
3. How to take Zolmitriptan Orodispersible Tablets
4. Possible side effects
5. How to store Zolmitriptan Orodispersible Tablets
6. Contents of the pack and other information

1. What Zolmitriptan Orodispersible Tablets is and what it is used for

Zolmitriptan Orodispersible Tablets contains zolmitriptan and belongs to a group of medicines called triptans.

Zolmitriptan Orodispersible Tablets is used to treat migraine headache.

  • Migraine symptoms may be caused by the widening of blood vessels in the head. Zolmitriptan Orodispersible Tablets is thought to reduce the widening of these blood vessels. This helps to take away the headache and other symptoms of a migraine attack, such as feeling or being sick (nausea or vomiting) and being sensitive to light and sound.
  • Zolmitriptan Orodispersible Tablets works only when a migraine attack has started. Do not use it to prevent a migraine attack.

2. What you need to know before you take Zolmitriptan Orodispersible Tablets

Do not take Zolmitriptan Orodispersible Tablets:

  • if you are allergic to zolmitriptan or any of the other ingredients of this medicine (listed in section 6)
  • if you have high blood pressure
  • if you have, or previously had heart problems, including a heart attack, angina (chest pain caused by exercise or effort), Prinzmetal’s angina (a chest pain which occurs at rest) or have experienced heart related symptoms such as shortness of breath or pressure in the chest
  • if you have, or previously had a stroke or short-lasting symptoms similar to a stroke (transient ischaemic attack or TIA)
  • if you are at the same time taking some other medicines for your migraine (e.g. ergotamine or ergot-type medicines like dihydroergotamine and methysergide) or other triptan medicines for migraine. See section on ‘Other medicines and Zolmitriptan Orodispersible Tablets’ for further information.

If you are not sure if any of these apply to you, talk to your doctor or pharmacist

Warnings and precautions

Talk to your doctor or pharmacist before taking Zolmitriptan Orodispersible Tablets. Let your doctor know if:

  • you are at risk of getting ischaemic heart disease (poor blood flow in the arteries of the heart). Your risk is greater if you smoke, have high blood pressure, high levels of cholesterol, diabetes or if anyone in your family has ischeamic heart disease
  • you have been told that you have Wolff-Parkinson-White Syndrome (a type of abnormal heart beat)
  • you have, or previously had liver problems
  • you have headaches which are not like your usual migraine headache
  • you are taking other medicines for the treatment of depression (see section below for ‘Other medicines and Zolmitriptan Orodispersable Tablets’ for further information).

If you go into hospital, please ensure you tell the medical staff that you are taking Zolmitriptan Orodispersible Tablets.

Zolmitriptan Orodispersible Tablets is not recommended for individuals aged less than 18 years, or over the age of 65 years.

As with other migraine treatments, taking too much Zolmitriptan Orodispersible Tablets can cause daily headaches or can make your migraine headaches worse. Let your doctor know if you think that this applies to you, as you may need to stop taking Zolmitriptan Orodispersible Tablets to correct the problem.

Other medicines and Zolmitriptan Orodispersable Tablets

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including those medicines and herbal medicines obtained without a prescription.

In particular, tell your doctor if you are taking any of the following medicines:

Medicines used for migraine

  • If you take another type of triptan (such as sumatriptan or naratriptan) which is different from this medicine, leave 24 hours before taking Zolmitriptan Orodispersible Tablets.
  • After taking Zolmitriptan Orodispersible Tablets, leave 24 hours before taking another type of triptan.
  • If you take medicines that contain ergotamine or ergot-type medicines (such as dihydroergotamine or methysergide), leave 24 hours before taking Zolmitriptan Orodispersible Tablets.
  • After taking Zolmitriptan Orodispersible Tablets, leave 6 hours before taking ergotamine or ergot-type medicines.

Medicines used for depression

  • Mono-amine Oxidase Inhibitors, (also known as MAOIs) such as moclobemide.
  • Medicines called SSRIs (selective serotonin reuptake inhibitors) such as fluoxetine, paroxetine, fluvoxamine or sertraline.
  • Medicines called SNRIs (serotonin norepinephrine reuptake inhibitors) such as venlafaxine or duloxetine.

Other medicines

  • cimetidine (for indigestion or stomach ulcers)
  • a quinolone antibiotic (such as ciprofloxacin)

If you are using herbal remedies containing St John’s Wort (Hypericum perforatum), at the same time as this medicine, potential side effects of Zolmitriptan Orodispersible Tablets may occur. Stop taking this medicine and let your doctor know.

Zolmitriptan Orodispersible Tablets with food and drink

You can take Zolmitriptan Orodispersible Tablets with or without food. It does not affect the way that Zolmitriptan Orodispersible Tablets works.

Pregnancy, breast-feeding and fertility

If you are pregnant or breast-feeding think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

  • It is not known if taking Zolmitriptan Orodispersible Tablets during pregnancy is harmful. Before taking Zolmitriptan Orodispersible Tablets, tell your doctor if you are pregnant or trying to become pregnant.
  • The active substance in your medicine may pass into your breast milk. To minimise the risk of exposing your baby to your medicine you should not breast-feed for 24 hours after taking zolmitriptan.

Driving and using machines

  • During a migraine attack your reactions may be slower than usual. Take precaution when driving or using any tools or machines that requires concentration.
  • Zolmitriptan Orodispersible Tablets is unlikely to affect your ability to drive or use tools or machines. However, it may make you feel sleepy. Wait to see how Zolmitriptan Orodispersible Tablets affects you before you perform these activities.

Zolmitriptan Orodispersible Tablets contains Aspartame (E951)

Zolmitriptan Orodispersible Tablets contains aspartame (E951). Aspartame contains a source of phenylalanine and may be harmful for people with phenylketonuria. Talk to your doctor before taking this medicine.

3. How to take Zolmitriptan Orodispersible Tablets

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

The recommended dose is 2.5 mg or 5 mg. Zolmitriptan Orodispersible Tablets is used to treat migraine attacks. Take Zolmitriptan Orodispersible Tablets as soon as possible after your migraine headache has started. You can also take it once an attack is underway.

If the symptoms of migraine return within 24 hours, you may take a second dose of zolmitriptan. The second dose should not be taken within 2 hours of your first dose.

If the tablets did not relieve your migraine, tell your doctor. Your doctor may raise the dose to 5 mg or change your treatment.

Do not use more than two doses in one day. The maximum daily dose is 10 mg zolmitriptan.

Method of administration

Oral Use.

Peel the blister pack open as shown on the foil. Do not push the tablet through the foil.

Place the tablet on your tongue, where it will dissolve and be swallowed with the saliva. You do not have to take a drink of water in order to swallow your tablet.

If you take more Zolmitriptan Orodispersible Tablets than you should

If you have taken more Zolmitriptan Orodispersible Tablets than prescribed by your doctor, tell your doctor or go to the nearest hospital straight away. Take the Zolmitriptan Orodispersible Tablets medicine with you.

If you forget to take Zolmitriptan Orodispersible Tablets

Do not take a double dose to make up for a forgotten tablet.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. Some of the symptoms below could be part of the migraine attack itself.

Rare (may affect up to 1 in 1,000 people)

  • Allergic/hypersensitivity reactions including itchy rash (urticaria) and swelling of the face, lips, mouth, tongue and throat. If you think Zolmitriptan Orodispersible Tablets is causing an allergic reaction, stop using it and contact your doctor straight away.

Very rare (may affect up to 1 in 10,000 people)

  • Angina (pain in the chest, often brought on by exercise), heart attack or spasm of the blood vessels of the heart. If you notice chest pain or shortness of breath after taking Zolmitriptan Orodispersible Tablets, contact your doctor and do not take any more Zolmitriptan Orodispersible Tablets.
  • Spasm of the blood vessels of the gut, which can cause damage to your gut. You may notice stomach pain or bloody diarrhoea. If this happens, contact your doctor and do not take any more Zolmitriptan Orodispersible Tablets.
  • Bleeding in the brain (cerebral bleeding) or stroke.

Other possible side effects:

Common (may affect up to 1 in 10 people):

These side effects are usually mild and go away after a short time.

  • Abnormal sensations such as tingling in your fingers and toes or skin that is sensitive to touch.
  • Feeling sleepy, dizzy or warm.
  • Headache.
  • Uneven heart beat.
  • Feeling sick (nausea) or being sick (vomiting).
  • Stomach pain.
  • Dry mouth.
  • Muscle weakness or muscle pain.
  • Feeling weak.
  • Heaviness, tightness, pain or pressure in the throat, neck, arms and legs, or chest.
  • Problems swallowing

Uncommon (may affect up to 1 in 100 people):

  • Very fast heart beat.
  • Slightly higher blood pressure.
  • Increase in the amount of water you pass (urine) or in how often you need to pass water.

Reporting of side effects

If you get any of the side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Zolmitriptan Orodispersible Tablets

Keep this medicine out of the sight and reach of children.

Do not use this mediicne after the expiry date which is stated on the carton after EXP: The expiry date refers to the last day of that month.

  • This medicinal product does not require any special storage conditions.
  • Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.

6. Contents of the pack and other information

What Zolmitriptan Orodispersible Tablets contains

2.5mg

The active substance is zolmitriptan. Zolmitriptan 2.5 mg Orodispersible Tablets contain 2.5 mg of zolmitriptan.

The other ingredients are Mannitol (E421), Cellulose microcrystalline, Crospovidone Type A, Aspartame (E951), Silica colloidal anhydrous, Talc, Magnesium Stearate, Peppermint Flavour.

5mg

The active substance is zolmitriptan. Zolmitriptan Orodispersible 5 mg Tablets contain 5 mg of zolmitriptan.

The other ingredients are Mannitol (E421), Cellulose microcrystalline, Crospovidone Type A, Aspartame (E951), Silica colloidal anhydrous, Talc, Magnesium Stearate, Peppermint Flavour.

What Zolmitriptan Orodispersible Tablets looks like and contents of the pack

Zolmitriptan 2.5 mg Orodispersible Tablets are supplied as:

White to off-white, round tablets debossed ‘F7’ on one side and plain on other side (diameter approximately: 6,5 mm).

Zolmitriptan 5 mg Orodispersible Tablets are supplied as:

White to off-white, round tablets debossed ‘F11’ on one side and plain on other side (diameter approximately: 8 mm).

Zolmitriptan 2.5 mg Orodispersible Tablets are available in Aluminium/Aluminium peelable blisters in cartons containing 2, 3, 4, 5, 6, 12, 18 tablets.

Zolmitriptan 5 mg Orodispersible Tablets are available in Aluminium/Aluminium peelable blisters in cartons containing 2, 3, 4, 5, 6, 12, 18 tablets.

Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder

Glenmark Pharmaceuticals Europe Limited
Laxmi House
2-B Draycott Avenue
Kenton
Harrow
Middlesex
HA3 0BU
United Kingdom

Manufacturer

Glenmark Pharmaceuticals s.r.o.
Fibichova 143
Vysoké Mýto
566 17
Czech Republic

Glenmark Pharmaceuticals Europe Limited
Building 2
Croxley Green Business Park
Croxley Green
Hertfordshire
WD18 8YA
United Kingdom

This leaflet was last revised in 03/2016.